Evidence map›Paper›PMID 39807517›Full record

ArticleHeliyon2025

A co-registration method to validate

Rowan W Sanderson, Renate Zilkens, Peijun Gong, Imogen Boman, Ken Y Foo, Skandha Shanthakumar, James Stephenson, Wei Ling Ooi, José Cid Fernandez, Synn Lynn Chin and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Rowan W SandersonBRITElab, Harry Perkins Institute of Medical Research, QEII Medical Centre Nedlands and Centre for Medical Research, The University of Western Australia, Perth, Australia.
Renate ZilkensBRITElab, Harry Perkins Institute of Medical Research, QEII Medical Centre Nedlands and Centre for Medical Research, The University of Western Australia, Perth, Australia.
Peijun GongBRITElab, Harry Perkins Institute of Medical Research, QEII Medical Centre Nedlands and Centre for Medical Research, The University of Western Australia, Perth, Australia.
Imogen BomanBRITElab, Harry Perkins Institute of Medical Research, QEII Medical Centre Nedlands and Centre for Medical Research, The University of Western Australia, Perth, Australia.
Ken Y FooBRITElab, Harry Perkins Institute of Medical Research, QEII Medical Centre Nedlands and Centre for Medical Research, The University of Western Australia, Perth, Australia.
Skandha ShanthakumarOncoRes Medical, Perth, Western Australia, Australia.
James StephensonBreast Centre, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Wei Ling OoiBreast Centre, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
José Cid FernandezBreast Centre, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Synn Lynn ChinBreast Centre, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Lee JacksonBreast Centre, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Mireille HardiePathWest, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, WA, 6150, Australia.
Benjamin F DessauvagiePathWest, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, WA, 6150, Australia.
Anmol RijhumalPathWest, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, WA, 6150, Australia.
Saud HamzaBreast Centre, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Christobel M SaundersDivision of Surgery, Medical School, The University of Western Australia, Perth, Western Australia, Australia.
Brendan F KennedyBRITElab, Harry Perkins Institute of Medical Research, QEII Medical Centre Nedlands and Centre for Medical Research, The University of Western Australia, Perth, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast-conserving surgery accompanied by adjuvant radiotherapy is the standard of care for patients with early-stage breast cancer. However, re-excision is reported in 20-30 % of cases, largely because of close or involved tumor margins in the specimen. Several intraoperative tumor margin assessment techniques have been proposed to overcome this issue, however, none have been widely adopted. Furthermore, tumor margin assessment of the excised specimen provides only an indirect indication of residual cancer in the patient following excision of the primary tumor. Handheld optical coherence tomography (OCT) probes and their functional extensions have the potential to detect residual cancer

Identifiers

PMID39807517
PMCPMC11728906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.